|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07D 401/14 | (2006.01) |
| A61K 31/53 | (2006.01) | ||
| A61P 35/00 | (2006.01) |
| (11) | Number of the document | 3216793 |
| (13) | Kind of document | T |
| (96) | European patent application number | 17162947.0 |
| Date of filing the European patent application | 2009-05-21 | |
| (97) | Date of publication of the European application | 2017-09-13 |
| (45) | Date of publication and mention of the grant of the patent | 2019-03-27 |
| (46) | Date of publication of the claims translation | 2019-05-10 |
| (30) | Number | Date | Country code |
| 55661 P | 2008-05-23 | US |
| (72) |
VENKATESAN, Aranapakam M., US
CHEN, Zecheng, US
DEHNHARDT, Christoph M., US
DOS SANTOS, Osvaldo, US
DELOS SANTOS, Efren Guillermo, US
ZASK, Arie, US
VERHEIJEN, Jeroen C., US
KAPLAN, Joshua Aaron, US
RICHARD, David J., US
AYRAL-KALOUSTIAN, Semiramis, US
MANSOUR, Tarek S., US
GOPALSAMY, Ariamala, US
CURRAN, Kevin J., US
SHI, Mengxiao, US
|
| (73) |
Wyeth LLC,
235 East 42nd Street, New York, NY 10017-5755,
US
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Triazino junginiai, kaip P13 kinazės ir mTOR inhibitoriai |
| TRIAZINE COMPOUNDS AS P13 KINASE AND MTOR INHIBITORS |
| Payment date | Validity (years) | Amount | |
| 2025-05-05 | 17 | 347.00 EUR |
| 2026-05-21 |